Healthcare / Medical Care FacilitiesTokyo
$2950.00
+69.00 (+2.38%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-1.5B · quality 33.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$13.1B
P/E
17.4x
↓EV/EBITDA
14.6x
↑ROE
11.5%
↑Gross Margin
13.4%
↓Debt/Equity
0.85
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+19.8%
FCF CAGR
—
FCF margin
12.0%
FCF / Net income
3.42x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $17.21B · net income $607.0M · FCF $2.07B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $17.21B | $17.21B | $13.84B | $11.99B | $10.00B |
| Net Income | $607.0M | $607.0M | $325.0M | $365.0M | $956.0M |
| EBITDA | $1.13B | $1.13B | $991.0M | $1.51B | $2.08B |
| EPS | 133.10 | 133.10 | 69.86 | 77.45 | — |
| Gross Margin | 13.4% | 13.4% | 11.8% | 10.8% | 15.9% |
| Operating Margin | 4.5% | 4.5% | 2.3% | 0.2% | 4.6% |
| Net Margin | 3.5% | 3.5% | 2.3% | 3.0% | 9.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.85 | 0.85 | 1.14 | 1.00 | 0.79 |
| Current Ratio | 1.49 | 1.49 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.07B | $2.07B | $-1.47B | $-1.92B | $-507.0M |
| Returns | |||||
| ROE | 11.5% | 11.5% | 6.6% | 7.9% | 22.6% |
| Valuation | |||||
| P/E | 17.37 | 17.37 | 9.58 | 14.58 | — |
| EV/EBITDA | 14.60 | 14.60 | 8.02 | 5.69 | 5.34 |
| P/B | 2.55 | 2.55 | 0.63 | 1.15 | 2.10 |
| Growth & Yield | |||||
| Revenue Growth | 24.3% | 24.3% | 15.4% | 19.9% | — |
| EPS Growth | 90.5% | 90.5% | -9.8% | — | — |
| Dividend Yield | 0.9% | 0.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
25.3%
EPS terminal req.
$261.76
Spread vs growth
65.2%
5Y implied EPS CAGR
18.9%
EPS terminal req.
$316.73
Spread vs growth
71.6%
10Y implied EPS CAGR
14.4%
EPS terminal req.
$510.10
Spread vs growth
76.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+41.2%
Start / end P/E
30.3x → 22.3x
EPS bridge
69.86 → 133.10
Residual
-23.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.